---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-059400"
form_type: "8-K"
ticker: "CLRB"
cik: "0001279704"
company_name: "Cellectar Biosciences, Inc."
filed_at: "2025-06-13T23:59:59+00:00"
generated_at: "2026-05-19T07:38:54.973712+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Cellectar shareholders approve reverse stock split, re-elect directors

## Summary
- Elected James V. Caruso and Frederick W. Driscoll as Class II directors; Caruso 5,478,892 for, Driscoll 6,207,218 for.
- Ratified Deloitte & Touche as independent auditor for FY2025 with 16,651,803 votes for, 219,578 against.
- Approved reverse stock split of common stock at ratio 1:10 to 1:30, as determined by Board; 13,464,719 for.
- Approved non-binding advisory vote on named executive officer compensation: 5,050,203 for, 2,230,519 against.

## SEC filing metadata
- accession: 0001104659-25-059400
- form_type: 8-K
- ticker: CLRB
- cik: 0001279704
- company_name: Cellectar Biosciences, Inc.
- filed_at: 2025-06-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1279704/000110465925059400/0001104659-25-059400-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1279704/000110465925059400/tm2517987d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-059400
- JSON: https://secwatch.observer/filing/0001104659-25-059400.json
- Plain text: https://secwatch.observer/filing/0001104659-25-059400.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.